Search

Search Results

• 

  Contribution of the new 2012 EULAR/ACR classification criteria for the diagnosis of polymyalgia rheumatica

  F. Muratore, C. Salvarani, P. Macchioni

  18-22

  27-03-2018

  Published: 27 March 2018

  2888

  PDF: 1616
• 

  Pathogenesis of polymyalgia rheumatica

  G. Guggino, A. Ferrante, F. Macaluso, G. Triolo, F. Ciccia

  10-17

  27-03-2018

  Published: 27 March 2018

  6518

  PDF: 3995
• 

  Update on treatment of polymyalgia rheumatica

  D. Camellino, C. Dejaco

  59-66

  27-03-2018

  Published: 27 March 2018

  5725

  PDF: 3320
• 

  Imaging in polymyalgia rheumatica

  N. Possemato, C. Salvarani, N. Pipitone

  51-58

  27-03-2018

  Published: 27 March 2018

  4192

  PDF: 2152
• 

  Comorbidity in polymyalgia rheumatica

  C. Chatzigeorgiou, S.L. Mackie

  35-43

  27-03-2018

  Published: 27 March 2018

  3429

  PDF: 2011
• 

  The real evidence for polymyalgia rheumatica as a paraneoplastic syndrome

  S. Muller, S. Hider, T. Helliwell, R. Partington, C. Mallen

  23-34

  27-03-2018

  Published: 27 March 2018

  5435

  PDF: 2536
• 

  Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica

  B.D. Nielsen, B. Dasgupta

  1-9

  27-03-2018

  Published: 27 March 2018

  2104

  PDF: 1539
• 

  The role of the general practitioner and the out-of-hospital public rheumatologist in the diagnosis and follow-up of patients with polymyalgia rheumatica

  A. Sobrero, C. Manzo, A. Stimamiglio

  44-50

  27-03-2018

  Published: 27 March 2018

  2334

  PDF: 1238
• 

  Giant cell arteritis and polymyalgia rheumatica as first manifestation of typical pulmonary carcinoid tumor

  T. Aguiar, M. B. Vincent

  165-168

  23-05-2016

  Published: 23 May 2016

  1966

  PDF: 857

• Did the first description of patients with polymyalgia rheumatica take place in Scotland or in Denmark?

  C. Manzo, M. Isetta, A. Castagna

  22-03-2024

  Published: 22 March 2024

  1907

  PDF: 510

• Baricitinib in polymyalgia rheumatica and giant cell arteritis: report of six cases

  Dario Camellino, Christian Dejaco, Franco Martini, Renzo Cosso, Gerolamo Bianchi

  28-10-2024

  Published: 28 October 2024

  1019

  PDF: 81

• After what time interval are we justified to diagnose immune checkpoint inhibitor-mediated polymyalgia rheumatica?

  Ciro Manzo, Marco Isetta

  03-03-2025

  Published: 3 March 2025

  657

  PDF: 83
• 

  Red cell distribution width is a potential predictor of early relapse in polymyalgia rheumatica

  D. Soddu, D. Sola, M. Bellan, E. Boin, M.G. Cittone, E. Zecca, E. Matino, R. Pedrazzoli, E. Rizzi, A.R. Pedrinelli, S. Tonello, V. Vassia, R. Landi, M. Pirisi, P.P. Sainaghi

  117-121

  03-08-2021

  Published: 3 August 2021

  2729

  PDF: 536
• 

  Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study

  M. Rossini, O. Viapiana, M. Vitiello, N. Malavolta, G. La Montagna, S. Maddali Bongi, O. Di Munno, R. Nuti, C.U. Manzini, C. Ferri, L. Bogliolo, A. Mathieu, F. Cantatore, A. Del Puente, M. Muratore, W. Grassi, B. Frediani, G. Saviola, P. Delvino, L. Mirone, G. Ferraccioli, G. Tripi, I. Piazza, D. Gatti

  30-39

  22-05-2017

  Published: 22 May 2017

  4361

  PDF: 2967
• 

  The Italian Society of Rheumatology clinical practice guidelines for the management of polymyalgia rheumatica

  N. Ughi, G.D. Sebastiani, R. Gerli, C. Salvarani, S. Parisi, A. Ariani, I. Prevete, M. Manara, F. Rumi, C.A. Sciré, A. Bortoluzzi

  1-15

  10-04-2020

  Published: 10 April 2020

  5678

  PDF: 3232
• 

  Giant cell arteritis associated with chronic active Epstein-Barr virus infection

  A. Giardina, A. Rizzo, A. Ferrante, G. Capra, G. Triolo, F. Ciccia

  36-39

  28-03-2013

  Published: 28 March 2013

  2831

  PDF: 822

• The support of the ultrasonography of the shoulder in the diagnosis of polymyalgia rheumatica with normal erythrocyte sedimentation rate

  A. Zaccaria, G. Latinakis, M. Oliveri, T. Maio, G. Frisone, F. Versace

  290-297

  Published:

  1026

  PDF: 1779

• Therapy of rheumatic polymyalgia: the pathophysiologic management

  M. Cutolo, M. Olivieri, M.E. Secchi, M.A. Cimino

  271-279

  Published:

  1443

  PDF: 2055

• Magnetic resonance imaging of the joints: a revolution for the practicing rheumatologist

  M.A. Cimmino

  239-241

  Published:

  987

  PDF: 645
• 

  Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab

  F.M. Perrotta, S. Scriffignano, M. Fatica, M. Specchia, E. Lubrano

  178-181

  19-11-2020

  Published: 19 November 2020

  1151

  PDF: 692
• 

  Reply to the Letter to the Editor: The Italian Society of Rheumatology clinical practice guidelines for the management of polymyalgia rheumatica

  N. Ughi, G.D. Sebastiani, R. Gerli, C. Salvarani, S. Parisi, A. Ariani, I. Prevete, M. Manara, F. Rumi, C.A. Scirè, A. Bortoluzzi

  122-123

  23-07-2020

  Published: 23 July 2020

  813

  PDF: 771
• 

  Clinical practice guidelines for patients with polymyalgia rheumatica: the need for an active involvement of all stakeholder is still unmet

  C. Manzo

  120-121

  23-07-2020

  Published: 23 July 2020

  898

  PDF: 691